Hamdard Laboratories starts clinical trials for their COVID immunity booster drugs


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ hamdard-laboratories-clinical-trials-for-covid-immunity-booster-drugs
Hamdard's Ayush Ministry backed study program starts

Health and wellness firm Hamdard Laboratories on September 7 said it is going to start clinical trial of its two immunity boosting medicines to assess their effectiveness in preventing COVID-19 infection.

The company has received all the regulatory approvals to begin the proof of concept clinical trial for its Infuza and Kulzam drugs, Hamdard Laboratories said in a statement.

A research team from Hamdard Institute of Medical Sciences and Research (HIMSR) is going to start the clinical trial at HAH Centenary Hospital in New Delhi, it added.

“A research group of HIMSR, that comprises an allopathic doctor, unani hakim, microbiologist and biochemist is working on a randomised, parallel group clinical trial for the repurposing of two popular Hamdard medicines i.e. Infuza and Kulzum for the prevention of COVID-19 infection,” Hamdard Laboratories India (Medicine Division) Executive Trustee Asad Mueed said.

HIMSR and associated HAH Centenary Hospital CEO G N Qazi said: “We are going to start the clinical trial…to evaluate the efficacy of these drugs for the prevention of COVID-19 infection in high risk subjects.”

The study concept is approved by the Special Project Approval Committee, Ministry of AYUSH and has also been cleared by the Institutional Ethics Committee of the hospital, he added.

Started in 1906, Hamdard (India) is the reflection of the exemplary life of Hakeem Abdul Hameed. Through unending perseverance, imagination, innovation and a strong will to adapt to the times, he brought the dynamism of a new age to the philosophy and operation of Hamdard. Their pool of medical experts with extreme calibre pushed the organization forward with ever-evolving innovations. As a result not only did Hamdard become a premier pharmaceutical house but also today represents our nation on a global medicinal platform.

Tags : #Hamdard #HIMSR #HamdardCovidImmunityBoosters #Covidimmunityboosters #HakeemAbdulHameed #HamdardInstituteofMedicalSciences #LatestCovidClinicalTrialsNews #UnaniImmunityBoosters

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026